Browse studies

Find your next paid study

60 recruiting studies matching your filters

An Open-Label, Multicenter, Long-term Treatment Extension Study in Subjects Who Have Completed a Prior GlaxoSmithKline/TESARO-Sponsored Niraparib Study and Are Judged by the Investigator to Benefit From Continued Treatment With Niraparib

This is a global extension study to provide continued access to niraparib and further characterize the long-term safety of niraparib treatment in participants …

Ovarian NeoplasmsBreast Neoplasms

Estimated

~$10 – $7,500

GlaxoSmithKlineNCT04641247

Phase 4

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

The hypothesis of this study is that paclitaxel levels increase chromosomal instability (CIN) in tumors and this is lethal to tumors that have pre-existing CIN…

Breast Neoplasm Female

Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT03096418

Phase 1

HERTHENA-Breast-01: A Phase 1b/2, Multicenter, Open-label, Dose-Finding Study to Evaluate the Safety and Antitumor Activity of Patritumab Deruxtecan in Participants With HER2 Positive Unresectable Locally Advanced Breast Cancer or Metastatic Breast Cancer

Researchers want to learn if patritumab deruxtecan (MK-1022) can treat certain breast cancers. The breast cancers being studied are HER2 positive unresectable …

Breast NeoplasmsBreast Cancer

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT06686394

Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring

This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may …

Breast CarcinomaBreast Neoplasm

Estimated

~$10 – $750

Mayo ClinicNCT04799535

Phase 3

Sentinel Lymph Node Biopsy in Ductal Cancer in Situ or Unclear Lesions of the Breast and How to Not do it. An Open-label, Phase 3, Randomised Controlled Trial. (SentiNot 2.0).

The trial aims to investigate the use of superparamagnetic iron oxide (SPIO) nanoparticles as a tracer for delayed sentinel lymph node dissection (d-SLND) in p…

DCISBreast CancerBreast Neoplasms+1 more

Estimated

~$10 – $6,250

Uppsala UniversityNCT04722692

The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy

This study will determine how the intestinal microbiome differs between patients with obesity and early triple-negative breast cancer who achieve a pathologic …

Breast Neoplasms

Estimated

~$10 – $750

Pennington Biomedical Research CenterNCT06318507

Observational

A Randomized, Prospective Evaluation of Negative Pressure Wound Therapy on Abdominal Donor Site in Free Flap Breast Reconstruction in Obese Patients

This trial studies the safety and how well negative pressure wound therapy works in healing the abdominal incision in obese patients undergoing free flap breas…

Body Mass Index Greater Than or Equal to 30Malignant Breast NeoplasmMammoplasty Patient+1 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT04003038

Research Registry for Intra-Operative Radiotherapy (IORT) During Breast Conserving Surgery in Patients With in Situ and Early Stage Breast Cancer

This is a prospective, registry study that will enroll all women with early stage breast cancer who will be treated with intraoperative radiotherapy (IORT) dur…

Early-stage Breast CancerBreast Carcinoma in SituBreast Neoplasms

Estimated

~$10 – $1,125

Saint John's Cancer InstituteNCT04603209

Observational

Molecular Breast Imaging (MBI)-Guided Biopsy Pilot SBIR

The goal of this pilot clinical trial is to demonstrate supplemental screening MBI (molecular breast imaging) in women with dense breasts. The main questions i…

Breast Cancer DetectionBreast NeoplasmMolecular Imaging+2 more

Estimated

~$10 – $8,750

Smart Breast Corp.NCT07114679

Phase 4

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

To prospectively evaluate the efficacy and safety of DPYD-guided dosing strategies in a real-world clinical setting, specifically by comparing the incidence of…

Colorectal NeoplasmsBreast NeoplasmsHead and Neck Neoplasms+1 more

Estimated

~$10 – $6,250

Rutgers, The State University of New JerseyNCT07158164

Observational

Optimization of a Multicomponent Intervention to Foster Functional Recovery After Breast Cancer Treatment

The goal of this clinical trial is to determine the best way to promote participation in vocational, social, physical, and instrumental activities of daily liv…

Breast Neoplasms

Estimated

~$10 – $7,500

MGH Institute of Health ProfessionsNCT07489053

Phase 2

A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

This is a single institution phase II randomized study evaluating the potential benefits of a supplement, tart cherry juice at high- versus low-doses, to preve…

Breast CancerBreast Cancer Stage IBreast Cancer Stage II+34 more

Estimated

~$10 – $6,250